Correlation Between DiaMedica Therapeutics and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Kymera Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Kymera Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Kymera Therapeutics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between DiaMedica and Kymera is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Kymera Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.09 times more return on investment than Kymera Therapeutics. However, DiaMedica Therapeutics is 1.09 times more volatile than Kymera Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.05 per unit of risk. If you would invest 144.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 422.00 from holding DiaMedica Therapeutics or generate 293.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Kymera Therapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Kymera Therapeutics |
DiaMedica Therapeutics and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Kymera Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Kymera Therapeutics vs. DiaMedica Therapeutics | Kymera Therapeutics vs. Lyra Therapeutics | Kymera Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |